rs192665139

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001318510.2(ACSL4):​c.1391-7T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000657 in 1,195,951 control chromosomes in the GnomAD database, including 3 homozygotes. There are 207 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0034 ( 3 hom., 102 hem., cov: 23)
Exomes 𝑓: 0.00037 ( 0 hom. 105 hem. )

Consequence

ACSL4
NM_001318510.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0001197
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.808

Publications

0 publications found
Variant links:
Genes affected
ACSL4 (HGNC:3571): (acyl-CoA synthetase long chain family member 4) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the cognitive disability or Alport syndrome. Alternative splicing of this gene generates multiple transcript variants. [provided by RefSeq, Jan 2016]
ACSL4 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: ClinGen, Illumina, Orphanet
  • intellectual disability, X-linked 63
    Inheritance: XL Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant X-109663409-A-G is Benign according to our data. Variant chrX-109663409-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 495142.
BS2
High Homozygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACSL4NM_001318510.2 linkc.1391-7T>C splice_region_variant, intron_variant Intron 12 of 15 ENST00000672401.1 NP_001305439.1 O60488-2Q8TAF6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACSL4ENST00000672401.1 linkc.1391-7T>C splice_region_variant, intron_variant Intron 12 of 15 NM_001318510.2 ENSP00000500273.1 O60488-2

Frequencies

GnomAD3 genomes
AF:
0.00335
AC:
376
AN:
112385
Hom.:
3
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00123
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000376
Gnomad OTH
AF:
0.000662
GnomAD2 exomes
AF:
0.000917
AC:
166
AN:
181080
AF XY:
0.000408
show subpopulations
Gnomad AFR exome
AF:
0.0117
Gnomad AMR exome
AF:
0.000258
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000248
Gnomad OTH exome
AF:
0.000449
GnomAD4 exome
AF:
0.000374
AC:
405
AN:
1083512
Hom.:
0
Cov.:
27
AF XY:
0.000300
AC XY:
105
AN XY:
349664
show subpopulations
African (AFR)
AF:
0.0124
AC:
323
AN:
26096
American (AMR)
AF:
0.000371
AC:
13
AN:
35079
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19262
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30115
South Asian (SAS)
AF:
0.000168
AC:
9
AN:
53617
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40483
Middle Eastern (MID)
AF:
0.000977
AC:
4
AN:
4093
European-Non Finnish (NFE)
AF:
0.00000603
AC:
5
AN:
829173
Other (OTH)
AF:
0.00112
AC:
51
AN:
45594
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00339
AC:
381
AN:
112439
Hom.:
3
Cov.:
23
AF XY:
0.00294
AC XY:
102
AN XY:
34639
show subpopulations
African (AFR)
AF:
0.0118
AC:
365
AN:
31021
American (AMR)
AF:
0.00123
AC:
13
AN:
10568
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2654
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3628
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2761
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6182
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000376
AC:
2
AN:
53196
Other (OTH)
AF:
0.000654
AC:
1
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00161
Hom.:
6
Bravo
AF:
0.00389

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Non-syndromic X-linked intellectual disability Uncertain:1
Jun 18, 2013
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jul 03, 2019
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.3
DANN
Benign
0.65
PhyloP100
0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00012
dbscSNV1_RF
Benign
0.0080
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs192665139; hg19: chrX-108906638; API